XML 31 R18.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Summary of Unaudited Quarterly Financial Information | 12 Months Ended
--- | ---
Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract] |
Summary of Unaudited Quarterly Financial Information | Summary of Unaudited Quarterly Financial Information As discussed in Correction of Previously Reported Financials in Note 1 of the previously filed Annual Report on Form 10-K on February 26, 2016, management opted to restate certain amounts in the previously reported financial statements as of and for the three and nine months ended September 30, 2015 to correct an immaterial error in the calculation of certain capital loss carry-forwards at September 30, 2015 related to the sale of the Avinza product line. The restated amounts are set forth in the following tables (in thousands, except share data):
| Three months ended, |  | Nine months ended,
| September 30, 2015 |  | September 30, 2015
| Previously Reported in 10-Q |  | Restated |  | Previously Reported in 10-Q |  | Restated
Income tax benefit | $ | 217,255 |  |  | $ | 219,362 |  |  | $ | 216,976 |  |  | $ | 219,083 |
Net income | 224,539 |  |  | 226,646 |  |  | 248,857 |  |  | 250,964 |
Basic net income per share | $ | 11.29 |  |  | $ | 11.40 |  |  | $ | 12.61 |  |  | $ | 12.71 |
Diluted net income per share | $ | 10.46 |  |  | $ | 10.56 |  |  | $ | 11.78 |  |  | $ | 11.88 |
| As of September 30, 2015
| Previously Reported in 10-Q |  | Restated
Long-term deferred tax assets | $ | 206,423 |  |  | $ | 208,530 |
Accumulated deficit | (410,458 | ) |  | (408,351 | )
In addition, As discussed in 2015 Restatement in Note 1 of this Annual Report on Form 10K/A, the Company corrected accounting errors related to its DTA at September 30, 2015 by restating the previously reported financial statements as of and for the three months and nine months ended September 30, 2015. The restated amounts are set forth in the following tables: The effects of these prior period corrections on the condensed consolidated statement of operations and comprehensive income are as follows
| Nine months ended September 30, 2015
| As Previously Reported in 10-K(1) |  | Adjustments |  | As Restated
Income tax benefit | $ | 219,083 |  |  | $ | (27,481 | ) |  | $ | 191,602 |
Net income | 250,964 |  |  | (27,481 | ) |  | 223,483 |
Comprehensive income | 251,351 |  |  | (27,481 | ) |  | 223,870 |
Basic earnings per share | 12.71 |  |  | (1.38 | ) |  | 11.33 |
Diluted earnings per share data | 11.88 |  |  | (1.30 | ) |  | 10.58 |
Basic | 19,887 |  |  | — |  |  | 19,887 |
Diluted | 21,122 |  |  | — |  |  | 21,122 |
| Three months ended September 30, 2015
| As Previously Reported in 10-K(1) |  | Adjustments |  | As Restated
Income tax benefit (expense) | $ | 219,362 |  |  | $ | (27,481 | ) |  | $ | 191,881 |
Net income | 226,646 |  |  | (27,481 | ) |  | 199,165 |
Comprehensive income | 222,981 |  |  | (27,481 | ) |  | 195,500 |
Basic earnings per share | 11.40 |  |  | (1.39 | ) |  | 10.01 |
Diluted earnings per share data | 10.56 |  |  | (1.28 | ) |  | 9.28 |
The effects of these prior period corrections on the condensed consolidated balance sheet is as follows
| As of September 30, 2015
| As Previously Reported in 10-K(1) |  | Adjustments |  | As Restated
Deferred income taxes | $ | 208,530 |  |  | $ | (27,481 | ) |  | $ | 181,049 |
Total assets | 523,807 |  |  | (27,481 | ) |  | 496,326 |
Accumulated deficit | (408,351 | ) |  | (27,481 | ) |  | (435,832 | )
Total stockholders' equity | 294,288 |  |  | (27,481 | ) |  | 266,807 |
Total liabilities and stockholders' equity | 523,807 |  |  | (27,481 | ) |  | 496,326 |
(1) The Company opted to restate certain amounts in the previously reported financial statements as of and for the three and nine months ended September 30, 2015 to correct an immaterial error in the calculation of certain capital loss carry-forwards at September 30, 2015 related to the sale of the Avinza product line, which amounted to $2.1 million. The corrections did not have any impact on the company's cash flow statements for any period. The following is a summary of the unaudited quarterly results of operations for the years ended December 31, 2015 and 2014 (in thousands).
| Quarter ended
| March 31 |  | June 30 |  | September 30 Restated |  | December 31
2015 |  |  |  |  |  |  |
Total revenues | $ | 14,602 |  |  | $ | 18,418 |  |  | $ | 17,701 |  |  | $ | 21,193 |
Total operating costs and expenses | 11,253 |  |  | 14,053 |  |  | 9,104 |  |  | 10,175 |
Income tax (expense) benefit | (15 | ) |  | (265 | ) |  | 191,881 |  |  | 514 |
Income from continuing operations | (89 | ) |  | 22,027 |  |  | 199,165 |  |  | 6,341 |
Net loss attributable to noncontrolling interests | (843 | ) |  | (1,537 | ) |  | — |  |  | — |
Net income | 754 |  |  | 23,564 |  |  | 199,165 |  |  | 6,341 |
Basic per share amounts: |  |  |  |  |  |  |
Net income | $ | 0.04 |  |  | $ | 1.19 |  |  | $ | 10.01 |  |  | $ | 0.32 |
Diluted per share amounts: |  |  |  |  |  |  |
Net income | $ | 0.04 |  |  | $ | 1.11 |  |  | $ | 9.28 |  |  | $ | 0.29 |
Weighted average shares—basic | 19,612 |  |  | 19,725 |  |  | 19,887 |  |  | 19,933 |
Weighted average shares—diluted | 20,631 |  |  | 21,276 |  |  | 21,460 |  |  | 21,542 |
2014 |  |  |  |  |  |  |
Total revenues | $ | 15,958 |  |  | $ | 10,608 |  |  | $ | 14,973 |  |  | $ | 22,999 |
Total operating costs and expenses | 10,858 |  |  | 9,250 |  |  | 11,441 |  |  | 13,363 |
Income tax expense | (53 | ) |  | 47 |  |  | (124 | ) |  | (280 | )
Income from continuing operations | 2,097 |  |  | 1,288 |  |  | 777 |  |  | 6,730 |
Net loss attributable to noncontrolling interests | — |  |  | (304 | ) |  | (503 | ) |  | (325 | )
Net income | 2,097 |  |  | 1,592 |  |  | 1,280 |  |  | 7,055 |
Basic per share amounts: |  |  |  |  |  |  |
Net income | $ | 0.10 |  |  | $ | 0.08 |  |  | $ | 0.06 |  |  | $ | 0.35 |
Diluted per share amounts: |  |  |  |  |  |  |
Net income | 0.10 |  |  | 0.07 |  |  | 0.06 |  |  | 0.34 |
Weighted average shares—basic | 20,601 |  |  | 20,738 |  |  | 20,417 |  |  | 19,878 |
Weighted average shares—diluted | 21,208 |  |  | 21,780 |  |  | 21,345 |  |  | 20,792 |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1570-108306 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration